Dopamine transporter endocytic determinants: Carboxy terminal residues critical for basal and PKC-stimulated internalization

Molecular and Cellular Neuroscience

Volumn 39, Issue 2, 2008, Pages 211-217

  Boudanova, Ekaterina ^a   Navaroli, Deanna M ^a   Stevens, Zachary ^a   Melikian, Haley E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Endocytosis; Moncamine; Reuptake; Trafficking; Transporter

Indexed keywords

ALANINE; DOPAMINE TRANSPORTER; NEUROTRANSMITTER; NEUROTRANSMITTER TRANSPORTER; PROTEIN KINASE C;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENDOCYTOSIS; ENZYME ACTIVATION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; WILD TYPE;

ALANINE; ANIMALS; BIOTINYLATION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENDOCYTOSIS; PC12 CELLS; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; RATS; TRANSFECTION;

EID: 52049099133     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.06.011     Document Type: Article

References (41)

1. Amara S.G., and Sonders M.S. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 51 (1998) 87-96
2. Bjerggaard C., Fog J.U., Hastrup H., Madsen K., Loland C.J., Javitch J.A., and Gether U. Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J. Neurosci. 24 (2004) 7024-7036
3. Boudanova E., Navaroli D.M., and Melikian H.E. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54 (2008) 605-612
4. Brooks D.J. Functional imaging studies on dopamine and motor control. J. Neural. Transm. 108 (2001) 1283-1298
5. Carlsson T., Bjorklund T., and Kirik D. Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy. Current Gene Therapy 7 (2007) 109-120
6. Carneiro A.M., and Blakely R.D. Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J. Biol. Chem. 281 (2006) 24769-24780
7. Carneiro A.M., Ingram S.L., Beaulieu J.-M., Sweeney A., Amara S.G., Thomas S.M., Caron M.G., and Torres G.E. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J. Neurosci. 22 (2002) 7045-7054
8. Chen N.H., Reith M.E., and Quick M.W. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers. Arch. 447 (2004) 519-531
9. Chen R., Tilley M.R., Wei H., Zhou F., Zhou F.M., Ching S., Quan N., Stephens R.L., Hill E.R., Nottoli T., Han D.D., and Gu H.H. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc. Natl. Acad. Sci. USA 103 (2006) 9333-9338
10. De Oliveira I.R., and Juruena M.F. Treatment of psychosis: 30 years of progress. J. Clin. Pharm. Ther. 31 (2006) 523-534
11. Farhan H., Reiterer V., Korkhov V.M., Schmid J.A., Freissmuth M., and Sitte H.H. Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J. Biol. Chem. 282 (2007) 7679-7689
12. Fog J.U., Khoshbouei H., Holy M., Owens W.A., Vaegter C.B., Sen N., Nikandrova Y., Bowton E., McMahon D.G., Colbran R.J., Daws L.C., Sitte H.H., Javitch J.A., Galli A., and Gether U. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51 (2006) 417-429
13. Gether U., Andersen P.H., Larsson O.M., and Schousboe A. Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27 (2006) 375-383
14. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
15. Granas C., Ferrer J., Loland C.J., Javitch J.A., and Gether U. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance p receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278 (2003) 4990-5000
16. Holton K.L., Loder M.K., and Melikian H.E. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8 (2005) 881-888
17. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 565-598
18. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., and Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA 95 (1998) 4029-4034
19. Li L.B., Chen N., Ramamoorthy S., Chi L., Cui X.N., Wang L.C., and Reith M.E. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279 (2004) 21012-21020
20. Loder M.K., and Melikian H.E. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278 (2003) 22168-22174
21. Melikian H.E. Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol. Ther. 104 (2004) 17-27
22. Melikian H.E., and Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19 (1999) 7699-7710
23. Miranda M., Dionne K.R., Sorkina T., and Sorkin A. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell. 18 (2007) 313-323
24. Miranda M., Wu C.C., Sorkina T., Korstjens D.R., and Sorkin A. Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C. J. Biol. Chem. 280 (2005) 35617-35624
25. Nestler E.J. Is there a common molecular pathway for addiction?. Nat. Neurosci. 8 (2005) 1445-1449
26. Robinson M.B. Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80 (2002) 1-11
27. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
28. Runyon S.P., and Carroll F.I. Dopamine transporter ligands: recent developments and therapeutic potential. Curr. Top. Med. Chem. 6 (2006) 1825-1843
29. Schmid J.A., Scholze P., Kudlacek O., Freissmuth M., Singer E.A., and Sitte H.H. Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276 (2001) 3805-3810
30. Scholze P., Freissmuth M., and Sitte H.H. Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J. Biol. Chem. 277 (2002) 43682-43690
31. Sorkina T., Hoover B.R., Zahniser N.R., and Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6 (2005) 157-170
32. Sorkina T., Doolen S., Galperin E., Zahniser N.R., and Sorkin A. Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J. Biol. Chem. 278 (2003) 28274-28283
33. Sorkina T., Miranda M., Dionne K.R., Hoover B.R., Zahniser N.R., and Sorkin A. RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J. Neurosci. 26 (2006) 8195-8205
34. Torres G.E., Gainetdinov R.R., and Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4 (2003) 13-25
35. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.D., and Caron M.G. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278 (2003) 2731-2739
36. Torres G.E., Yao W.D., Mohn A.R., Quan H., Kim K.M., Levey A.I., Staudinger J., and Caron M.G. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30 (2001) 121-134
37. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19 (1996) 319-340
38. Yamashita A., Singh S.K., Kawate T., Jin Y., and Gouaux E. Crystal structure of a bacterial homologue of Na+/Cl-dependent neurotransmitter transporters 437 (2005) 215-223
39. Zahniser N.R., and Doolen S. Chronic and acute regulation of Na+/Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92 (2001) 21-55
40. Zhu S.J., Kavanaugh M.P., Sonders M.S., Amara S.G., and Zahniser N.R. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 282 (1997) 1358-1365
41. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., and Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. USA 98 (2001) 1982-1987